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Plasmodium vivax malaria has been endemic
on the Korean peninsula for centuries (1). The
primary vector is believed to be Anopheles
sinensis, a zoophilic and facultatively anthropo-
philic mosquito, which breeds in fresh, sun-
exposed water such as that found in rice fields (2).
During the Korean War (1950–1953), U.S. troops
were exposed to malaria (3) and received weekly
chloroquine chemoprophylaxis. This regimen
generally succeeded in preventing malarial
attacks while U.S. troops were in the Republic of
Korea. As the troops returned home, however,
U.S. military hospitals were inundated with
cases of malaria—at one point, as many as 629
cases per week (3). More than 3,000 cases of
malaria were documented in U.S. troops that
served during the war. Subsequent U.S. military
research led to the current use of primaquine
therapy (4). The outbreak of malaria continued
on the peninsula after the armistice. In the 1960s
and 1970s, the Republic of Korea government
combined active and passive case detection with
extensive use of pesticides in an ambitious
eradication project (1). Indigenous transmission of
malaria appeared to cease in the mid-1970s, and in
1979 the Republic of Korea was declared malaria-
free by the World Health Organization (5).
In 1993, P. vivax  malaria reemerged in the
Republic of Korea along the western edge of the
Demilitarized Zone (DMZ) (6). Since the
reemergence, the annual number of cases has
increased geometrically, tripling (1995, 1996) or
quadrupling (1997) in each of the past 4 years
(Table 1). In 1997, the Republic of Korea Army
administered antimalarial chemoprophylaxis to
approximately 8,000 of its troops at greatest risk
(U.S. Army/Republic of Korea Army/Republic of
Korea Malaria Symposium, pers. comm.). U.S.
troops in Korea were not placed on antimalarial
chemoprophylaxis in 1997 after local and U.S.
Army experts concluded that personal protective
measures and community mosquito control would
adequately limit transmission (7).
Cases in 1997 were distributed as expected
from June to October, with a peak of 518 cases in
August (Table 2). As in past years, more than 80%
of the cases were associated with military service
along the western DMZ. During 1997, 34 cases of
P. vivax  malaria in U.S. troops were attributed to
exposure in the Republic of Korea. This number
includes 27 cases in U.S. Forces-Korea troops,
one case in a soldier stationed in Okinawa, Japan,
who was temporarily assigned to the Republic of
Korea in August 1997, and six cases in U.S. troops
exposed in the summer of 1996. The U.S. Forces-
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Plasmodium vivax malaria reemerged in the Republic of Korea in 1993. The
number of cases has tripled each year since, with more than 1,600 cases reported
in 1997. All 27 cases in U.S. troops resolved uneventfully with chloroquine/
primaquine therapy. Disease is localized along the western Demilitarized Zone and
presents minimal risk to tourists.
Table 1. Annual number of Plasmodium vivax malaria
cases in U.S. Forces-Korea (USFK), Republic of Korea
(ROK) Army, and ROK Civilians, 1993–1997
ROK ROK
Year USFK Army Civilians Total
1993   0        1     1        2
1994   1      18   20      39
1995   1      98   19    118
1996 11    285   71    367
1997 27 1,154 461 1,642296 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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between July 1, 1997, and September 30, 1997,
was estimated to be 0.5 cases per 1,000 per week.
The incidence northwest of the Imjin River was
approximately one case per 1,000 per week. Site-
specific rates, as well as rates for the Republic of
Korea Army, cannot be released because of
security concerns; however, the Republic of
Korea Army has 50 times more exposed soldiers
than does U.S. Forces-Korea.
The epidemic remains focused along the
western DMZ. Before 1997, almost all civilian
cases were attributed to exposure in areas within
10 km of the DMZ. In 1997, however, dozens of
cases occurred among civilians farther than 10
km from the DMZ. The area where U.S. troops are
exposed is strictly controlled; tourists are not
allowed in this area after dark. Other areas under
the Republic of Korea Army control, e.g., Yonchon
and Chorwon, are accessible to tourists but are
seldom visited. The risk to foreign tourists,
therefore, appears to be negligible at this time.
Of the 27 U.S. Forces-Korea cases, 18 were in
U.S. soldiers and 9 were in Korean soldier
augmentees to the U.S. Army. All cases were in
men 19 to 40 years of age (median 21.5 years).
With one exception, the cases occurred in junior
enlisted soldiers. As in the past 3 years, no cases
occurred in African American soldiers, who
account for almost 30% of the exposed U.S.
troops. This is consistent with the known natural
immunity against P. vivax in African Americans,
most of whom do not have the Duffy antigen on
their red blood cells (8). This relative immunity of
African Americans was also seen during the
Korean War (3). The time from onset of symptoms
to diagnosis was 1 to 25 days (median 5 days).
Three patients with mild illness were treated as
outpatients. All patients quickly recovered after
standard chloroquine therapy. All patients were
also treated with primaquine.
The Korean strain of P. vivax malaria has
been well characterized by both Korean and U.S.
medical personnel (1,3). This type of malaria is
termed “temperate climate” P. vivax  malaria (3).
Transmission is restricted to only a few summer
months, when the Korean peninsula is warm
enough to support the parasite’s reproductive
cycle in the mosquito (1,3). This Korean P. vivax
malaria is remarkable in that 40% to 50% of cases
have no symptoms until 6 to 9 months after
infection (3,9). The long incubation period
interferes with determining the start of the
transmission season. Malaria cases begin to occur
in the late spring or early summer, before the
weather is warm enough to support malaria
transmission. These early season cases, arising
from infections acquired the previous fall, blend
into and fuel infections transmitted each summer.
Another result of this long incubation period, given
the extraordinary (>90%) annual turnover in U.S.
troops, is the return of infected soldiers to the
United States before any symptoms appear.
Malaria in the Republic of Korea is also
characterized as epidemic or unstable because
conditions usually do not support widespread
disease (10). Factors contributing to this
instability include the extremely short transmis-
sion season and the zoophily of the major vector.
Areas with unstable malaria usually have low to
very low rates of disease but can occasionally
have high rates in response to climatic, livestock,
or sociopolitical aberrations (10). The current
epidemic may fit this pattern. Heavy rains from
1994 to 1996 led to widespread crop failures in the
Democratic Peoples Republic of Korea. As a
result, domestic farm animal populations, the
preferred source of blood for A. sinensis, fell
sharply. These factors may have contributed to
the geometric increase of disease, but the lack of
data makes this explanation speculative.
Most Korean officials perceive the current
epidemic to be a Democratic Peoples Republic of
Korea public health problem spilling over the
DMZ and discount the importance of indigenous
transmission in the Republic of Korea. Broad-
scale epidemiologic investigation is necessary to
confirm indigenous transmission. Although it is
Table 2. Monthly distribution of Plasmodium vivax
malaria cases in the Republic of Korea (ROK), by onset
of disease, 1997
ROK ROK
Month USFKa Army Civilian Total
Jan   0     0     0     0
Feb   0     0     0     0
Mar   0     5     2     7
Apr   1   10     3   14
May   0   31     4   35
Jun   0 145   38 183
Jul   2 260 102 364
Aug 11 317 190 518
Sep 10 320   75 405
Oct   3   55   38   96
Nov   0     9     9   18
Dec   0     2 NAb     2
aUSFK, U.S. Forces-Korea.
bNA, Not available.297 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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not known if the epidemic will continue its
geometric increase and geographic expansion in
1998, a decrease in disease without extensive
intervention seems unlikely.
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